SINOVAC BIOTECH LTD. |
||||||||
Reconciliations of Non-GAAP measures to the nearest comparable GAAP measures |
||||||||
For the six and twelve months ended December 31, 2017 and 2016 |
||||||||
(Expressed in thousands of U.S. Dollars, except for numbers of shares and per share data) |
||||||||
Six months ended December 31 |
Twelve months ended December 31 | |||||||
2017 |
2016 |
2017 |
2016 | |||||
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) | |||||
Income (loss) from continuing operations |
20,860 |
11,094 |
36,705 |
(3,058) | ||||
Adjustments: |
||||||||
Share-based compensation |
495 |
1,777 |
979 |
2,409 | ||||
Depreciation and amortization |
2,641 |
2,310 |
4,881 |
5,310 | ||||
Interest and financing expenses, net of interest income |
28 |
667 |
386 |
998 | ||||
Net other (income) expense |
91 |
136 |
(13) |
(100) | ||||
Income tax expense |
11,299 |
4,156 |
8,339 |
2,664 | ||||
Non-GAAP EBITDA |
35,414 |
20,140 |
51,277 |
8,223 | ||||
Income (loss) from continuing operations |
20,860 |
11,094 |
36,705 |
(3,058) | ||||
Add: Foreign exchange loss |
(1,188) |
539 |
(1,323) |
942 | ||||
Add: Share-based compensation |
495 |
1,777 |
979 |
2,409 | ||||
Non-GAAP net income (loss) from continuing operations |
20,167 |
13,410 |
36,361 |
293 | ||||
Net Income (loss) from continuing operaitons attributable to shareholders of Sinovac |
14,954 |
7,654 |
25,807 |
(2,934) | ||||
Add: Non-GAAP adjustments to net income from continuing operaitons |
(693) |
2,316 |
(344) |
3,351 | ||||
Non-GAAP net income attributable to shareholders of Sinovac from continuing operations for computing non-GAAP diluted earnings (loss) per share |
14,261 |
9,970 |
25,463 |
417 | ||||
Weighted average number of shares on a diluted basis |
57,250,279 |
57,154,463 |
57,101,191 |
56,949,083 | ||||
Diluted earnings (loss) per share from continuing operations |
0.26 |
0.13 |
0.45 |
(0.05) | ||||
Add: Non-GAAP adjustments to net income per share from continuing operatons |
(0.01) |
0.04 |
(0.01) |
0.06 | ||||
Non-GAAP Diluted earnings per share from continuing operations |
0.25 |
0.17 |
0.45 |
0.01 |